Although no research has been done to see if Doxil (liposomal doxorubicin) passes through human breast milk, the manufacturer does not recommend this drug for women who are breastfeeding. A nursing infant exposed to this drug could develop serious problems, as Doxil (like most chemotherapy medications) can be toxic.
Can I Take Doxil While Breastfeeding?
At this time, it is usually recommended that women not breastfeed during treatment with Doxil® (liposomal doxorubicin). Due to the possible risks to the child, the manufacturer states that breastfeeding women should not take this medication. If you are breastfeeding a child, you should talk with your healthcare provider before taking Doxil.
More Information on Breastfeeding and Doxil
Currently, no research has been done to see if Doxil passes through breast milk in humans. However, the nonliposomal formulation of doxorubicin (Adriamycin®) has been shown to pass through breast milk, so it is likely that Doxil does as well. Like most chemotherapy drugs, Doxil can be quite toxic, and an infant exposed to this medication through breast milk could develop serious problems.
Talking With Your Healthcare Provider
You should discuss Doxil and breastfeeding with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation and other treatment options, the two of you can make a shared decision that is right for you.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click